Cargando…
Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment
Mild cognitive impairment (MCI) is a prodrome of Alzheimer’s disease pathology. Cognitive impairment patients often have a delayed diagnosis because there are no early symptoms or conventional diagnostic methods. Exosomes play a vital role in cell-to-cell communications and can act as promising biom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727429/ https://www.ncbi.nlm.nih.gov/pubmed/36018182 http://dx.doi.org/10.4103/1673-5374.347740 |
_version_ | 1784845017416728576 |
---|---|
author | Chen, Bo Song, Li Yang, Juan Zhou, Wei-Ying Cheng, Yuan-Yuan Lai, Yu-Jie |
author_facet | Chen, Bo Song, Li Yang, Juan Zhou, Wei-Ying Cheng, Yuan-Yuan Lai, Yu-Jie |
author_sort | Chen, Bo |
collection | PubMed |
description | Mild cognitive impairment (MCI) is a prodrome of Alzheimer’s disease pathology. Cognitive impairment patients often have a delayed diagnosis because there are no early symptoms or conventional diagnostic methods. Exosomes play a vital role in cell-to-cell communications and can act as promising biomarkers in diagnosing diseases. This study was designed to identify serum exosomal candidate proteins that may play roles in diagnosing MCI. Mass spectrometry coupled with tandem mass tag approach-based non-targeted proteomics was used to show the differentially expressed proteins in exosomes between MCI patients and healthy controls, and these differential proteins were validated using immunoblot and enzyme-linked immunosorbent assays. Correlation of cognitive performance with the serum exosomal protein level was determined. Nanoparticle tracking analysis suggested that there was a higher serum exosome concentration and smaller exosome diameter in individuals with MCI compared with healthy controls. We identified 69 exosomal proteins that were differentially expressed between MCI patients and healthy controls using mass spectrometry analysis. Thirty-nine exosomal proteins were upregulated in MCI patients compared with those in control patients. Exosomal fibulin-1, with an area under the curve value of 0.81, may be a biomarker for an MCI diagnosis. The exosomal protein signature from MCI patients reflected the cell adhesion molecule category. In particular, higher exosomal fibulin-1 levels correlated with lower cognitive performance. Thus, this study revealed that exosomal fibulin-1 is a promising biomarker for diagnosing MCI. |
format | Online Article Text |
id | pubmed-9727429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-97274292022-12-08 Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment Chen, Bo Song, Li Yang, Juan Zhou, Wei-Ying Cheng, Yuan-Yuan Lai, Yu-Jie Neural Regen Res Research Article Mild cognitive impairment (MCI) is a prodrome of Alzheimer’s disease pathology. Cognitive impairment patients often have a delayed diagnosis because there are no early symptoms or conventional diagnostic methods. Exosomes play a vital role in cell-to-cell communications and can act as promising biomarkers in diagnosing diseases. This study was designed to identify serum exosomal candidate proteins that may play roles in diagnosing MCI. Mass spectrometry coupled with tandem mass tag approach-based non-targeted proteomics was used to show the differentially expressed proteins in exosomes between MCI patients and healthy controls, and these differential proteins were validated using immunoblot and enzyme-linked immunosorbent assays. Correlation of cognitive performance with the serum exosomal protein level was determined. Nanoparticle tracking analysis suggested that there was a higher serum exosome concentration and smaller exosome diameter in individuals with MCI compared with healthy controls. We identified 69 exosomal proteins that were differentially expressed between MCI patients and healthy controls using mass spectrometry analysis. Thirty-nine exosomal proteins were upregulated in MCI patients compared with those in control patients. Exosomal fibulin-1, with an area under the curve value of 0.81, may be a biomarker for an MCI diagnosis. The exosomal protein signature from MCI patients reflected the cell adhesion molecule category. In particular, higher exosomal fibulin-1 levels correlated with lower cognitive performance. Thus, this study revealed that exosomal fibulin-1 is a promising biomarker for diagnosing MCI. Wolters Kluwer - Medknow 2022-08-02 /pmc/articles/PMC9727429/ /pubmed/36018182 http://dx.doi.org/10.4103/1673-5374.347740 Text en Copyright: © Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Chen, Bo Song, Li Yang, Juan Zhou, Wei-Ying Cheng, Yuan-Yuan Lai, Yu-Jie Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
title | Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
title_full | Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
title_fullStr | Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
title_full_unstemmed | Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
title_short | Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
title_sort | proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727429/ https://www.ncbi.nlm.nih.gov/pubmed/36018182 http://dx.doi.org/10.4103/1673-5374.347740 |
work_keys_str_mv | AT chenbo proteomicsofserumexosomesidentifiedfibulin1asanovelbiomarkerformildcognitiveimpairment AT songli proteomicsofserumexosomesidentifiedfibulin1asanovelbiomarkerformildcognitiveimpairment AT yangjuan proteomicsofserumexosomesidentifiedfibulin1asanovelbiomarkerformildcognitiveimpairment AT zhouweiying proteomicsofserumexosomesidentifiedfibulin1asanovelbiomarkerformildcognitiveimpairment AT chengyuanyuan proteomicsofserumexosomesidentifiedfibulin1asanovelbiomarkerformildcognitiveimpairment AT laiyujie proteomicsofserumexosomesidentifiedfibulin1asanovelbiomarkerformildcognitiveimpairment |